NR3C1 and hematopoietic and lymphoid system neoplasm: Glucocorticoids (GCs) remain important drugs for blood cancers including CLL (217) and OGT has been shown to bind the glucocorticoid receptor (GR) and mediate transrepression of NFκB by O-GlcNAcylating RNA polymerase II (218).